3 results
To evaluate the intraocular pressure (IOP)-lowering efficacy and safety of 2 dose strengths of Bimatoprost SR in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT) after initial and repeated administrations
Primary Objective To evaluate long term safety and tolerability of LAI (590 mg) administered once daily (QD) for up to 12 months in subjects who were refractory to standard multi-drug treatment and failed to convert in Study INS-212. Secondary…
Primary Objective: Validation of T1rho&T2mapping in healthy volunteers and patients with an OCD of the talusSecondary objective: To quantify T1rho & T2 mapping in patients with osteochondrial defects against healthy volunteers with…